2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$181.10-$0.03 (-0.02%)
Price as of Aug 21, 2026 7:30 PM EDT- $10.2BMarket Cap
- 45.15%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$181.10-$0.03 (-0.02%)
RGEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $181.13 | ||
Change | +$0.84 (+0.47%) | ||
Open | $179.66 | ||
High | $182.43 | ||
Low | $175.75 | ||
Previous Close | $180.29 | ||
Volume | 1,098,988 | ||
30-Day Average Volume | 1,285,980 | ||
1-Week Change | 8.57% | ||
1-Month Change | 32.22% | ||
1-Year Change | 45.15% | ||
3-Year Change | 12.52% | ||
5-Year Change | -31.05% | ||
Fundamentals | |||
Shares Outstanding | 56.4M | ||
Total Assets | $3.0B | ||
Market Cap | $10.2B | ||
Enterprise Value | $10.2B | ||
Period: QTR TTM FY | |||
Revenue | $204.1M | ||
Net Income | $5.0M | ||
Free Cash Flow | $27.4M | ||
EBIT | $20.1M | ||
EBITDA | $39.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 259 | ||
Enterprise Value/Revenue | 50 | ||
P/B | 5 | ||
P/E | 2,013 | ||
PEG | -50 | ||
Price/Free Cash Flow | 373 | ||
Price/Operating Cash Flow | 312 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue